SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ethical Holdings (Ethcy) - seriously undervalued

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Joe Dancy who wrote (313)12/16/1998 10:36:00 PM
From: tim wilson  Read Replies (1) of 345
 
per the elan loan agreement; page 4--
within six months the company intends to offer shareholders rights to purchase convertible debt at a conversion price of $5 per ADS (same price as Elan) or the market price, whichever is higher.

management believes that the current stock price of $5 is low, and that over the next several months as the story is better understood, the stock will be higher, at which time additional financing could be pursued

-this is a company with around $20 million of annualized sales
- more cash than debt, excluding the elan convertible debt,
-a market capitalization of only $7.5 million,
- two new highly regarded and experienced executives with significant option incentives at $5 per share
-and strong ties to Elan's resources --business pipeline, financial and otherwise

seems to have limited risk and substantial upside

-Tim
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext